Barely a week has gone past since the government began piloting its COVID-19 contact-tracing app on the Isle of Wight, and the project already seems to be in trouble.
Sweden's Orexo has announced it has bought the exclusive US rights to GAIA’s deprexis, a digital therapy to help patients manage their symptoms of depression and one of the most researched
CSL Behring has signed a deal with US firm BrightInsight to develop digital health products to help patients with rare diseases manage their conditions.